White label – Pompe disease - ClinicalTrials.eu

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
- Cisplatin
- Pembrolizumab
+3
Study on the Safety and Effects of PBF-999 for Patients with Prader-Willi Syndrome

Not recruiting

2 1
Investigated Drugs:
- Pbf-999
Study on Imaging with 89Zr-Atezolizumab to Monitor Immune Responses in Patients with Metastatic Triple Negative Breast Cancer Using Atezolizumab and Drug Combination

Not recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer metastatic
- Triple negative breast cancer
Investigated Drugs:
Study Comparing Rituximab and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated Diseases:
- Relapsing-remitting multiple sclerosis
Investigated Drugs:
- Ocrelizumab
- Rituximab
Study on the Effect of a New Moisturiser with Paraffin and Liquid Paraffin on Preventing Eczema Relapse in Children

Not recruiting

3 1 1 1
Investigated Diseases:
- Eczema
- Dermatitis atopic
Investigated Drugs:
Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+5
Study on Upadacitinib for Adults with Active Axial Spondyloarthritis

Not recruiting

3 1
Investigated Diseases:
- Ankylosing spondylitis
- Axial spondyloarthritis
Investigated Drugs:
- Abt-494
+3
Study on ENX-101 for Treating Focal Epilepsy in Patients Using 1 to 4 Antiseizure Medications

Not recruiting

2 1
Investigated Diseases:
- Partial seizures
Investigated Drugs:
- Enx-101
Study on the Safety and Effects of NGI226 Microparticles for Patients with Achilles Tendinopathy

Not recruiting

2 1
Investigated Diseases:
- Tendon disorder
Investigated Drugs:
- Ngi226
Study on Trehalose Dihydrate for Treating Spinocerebellar Ataxia in Adults

Not recruiting

4 1
Investigated Diseases:
- Hereditary ataxia
Investigated Drugs:
- Trehalose Dihydrate (Ph.eur.)

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies